Andere talen Biotron Limited

Aandelen

BIT

AU000000BIT4

Beurs gesloten - Australian S.E. Andere beurzen 07:32:07 17-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,055 ^AUD	-3,51%		0,00%	-43,30%

05/04	Biotron behaalt primaire doelstellingen van fase twee HIV-studie; aandelen stijgen met 25%	MT
26/02	Biotron Limited rapporteert resultaten voor het halfjaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Biotron Meets Primary Objectives of Phase Two HIV Trial; Shares Surge 25%	05/04
Biotron Limited Reports Earnings Results for the Half Year Ended December 31, 2023	26/02
Biotron Secures Nearly AU$2 Million R&D Tax Rebate in Fiscal 2023	08/02
Biotron Limited Reports Earnings Results for the Full Year Ended June 30, 2023	25-08-23
Biotron Completes Dosing Segment of Phase Two COVID-19 Clinical Trial	16-08-23
Biotron Secures Second Site for COVID-19 Trial	12-05-23
Biotron Begins Phase Two COVID-19 Trial for Antiviral Medication	04-05-23
Biotron Completes Phase 2 HIV-1 Trial for Antiviral Drug	09-03-23
Biotron Limited Announces Completion of Phase 2 HIV-1 Clinical Trials	09-03-23
Biotron Limited Reports Earnings Results for the Half Year Ended December 31, 2022	17-02-23
Biotron Receives $958,000 R&D Tax Rebate for Drug Development Programs	18-11-22
Biotron Raising $2.7 Million for Clinical Trials, Drug Development; Shares Fall 20%	27-10-22
Biotron Completes Enrollment for Phase 2 HIV Trial; Shares Jump 7%	04-10-22
Biotron Starts Human Trials of COVID-19 Antiviral Drug; Shares Jump 13%	14-09-22
Biotron Completes Enrollment for Phase 2 HIV Trial in Thailand	23-08-22
Biotron Limited Reports Earnings Results for the Full Year Ended June 30, 2022	19-08-22
Biotron Limited Auditor Raises 'Going Concern' Doubt	19-08-22
Nanomix Corporation Announces Distribution Agreement for the eLab System with Biotron Ltd. in Israel	21-07-22
Biotron Secures US FDA Guidance for COVID-19 Antiviral Drug	30-05-22
Biotron Limited Receives Positive U.S. Food and Drug Administrations Guidance for COVID-19 Clinical Program	30-05-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Biotron Limited

Aandelen

BIT

AU000000BIT4

Andere talen

Filters